Relmada gains FDA backing for two registrational trials and reports 92% response with NDV-01 in bladder Cancer
Bristol Myers Squibb prices €5 billion senior unsecured notes offering
Touchlight unveils next-gen circular DNA portfolio for advanced gene therapies
Zydus Lifesciences posts Q2 FY26 PAT at Rs. 1,258.6 Cr
Johnson & Johnson gets FDA nod for new depression treatment
SOUKYA launches Rs. 125 crore, 100-bed AYUSH hospital in Bengaluru
AstraZeneca delivers double-digit growth
Gilead’s Trodelvy falls short on progression-free survival in key breast cancer trial
SMS Pharmaceuticals post Q2 FY26 consolidated PAT at Rs. 25.31 Cr
Caplin Point Laboratories reports Q2 FY26 consolidated PAT at Rs. 154.45 Cr
A bio-analytical Remote Regulatory Assessment was also conducted from October 30 to November 7, 2025, and concluded with no observations
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
